The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Deutsche Bank initiates Oxford Nanopore with 'buy' - target 190 pence
£15m dark pool trade yesterday at £0.97. Feels bullish
Excellent piece on YouTube called Illumina vs Oxford Nanopore | Long-read hacking by Bad Genome
Always a good sign, adding to the big director buys last month.
This becomes a more interesting share at the end of the month when the no takeover protection the company put in place since IPO launch (to enable company to mature without cheap takeover) ends...making them in my book a target for the likesif Illumina who faked a long reads process, but it's not in same league as Oxford long reads
Director buying.
Well let's hope we never see 90s again, trying to consolidate above £1, patience is key, I've a strong feeling we will look back on this price in shock it was ever this low
Sadly with UK biotechs while often the science is great the managers are self serving and third rate. One has to wait for a bid or JV from a major to see the science become a product.
36 months from the bottom wherever that is.
I’ve had funnier toothaches than watching this stock!
Will it ever get back to 2 / 3 quid?
I always have a saying if you think it cant fall any further it normally does
ONT should merge with Pacific Bio - who are roughly the same market cap but have actually underperformed us! ONT could reverse in and pick up a US listing at the same time….
Nice to see a little bounce before close. Let’s hope it holds. Crazy this was 2:80 only months ago
60-70p bottom is my guess
Is not a nice feeling, I hope we can finish above the 1 pound mark by tomorrow.
Crazy, there has been lots of director buys and recently 2 broker buys yet it keeps making low every day.
Is there no bottom to this stock price!! Topped up at 98p to average down.. hoping that its now in bargain territory but it keeps falling…
Look on the brightside, at least their stock doesn't get reverse split due to a delisting notice as PACB in the US will.
They took a hammering yesterday after they've been edging down over the past few weeks. Hard to deny there wasn't a leak.
Still solvent, but PACB in volatile territory.
SP absolutely sh*t but the ONT staff got a nice little bonus.
94p - shameful
Only 2p left now - not been a good year for this stock
Certainly has been crushed for many months now - notice citigroup put out a buy rec and target of 210 friday
Probably very likely now but this is bargain basement territory, I'm very tempted to purchase
No doubt
Cefncribwr : Nothing new there. Mgmt already declared that on the most recent earnings call.
I don't mind adding a bit at these levels...small amount to lose.
Just need this story to play out. All sequencer companies are being hammered.
Sell recommendation in current edition of IC, stating that the point of profitability has been pushed even further into the future.